Find and Pitch Jounalists, Get Your Story Covered

Tags: Acino M8 Pharmaceuticals acquisition Camber Pharmaceuticals Generic Alesse

	Profile	Recent Articles on Subject
1	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	With uncertainty roiling Big Pharma, execs are placing lower-risk bets - 25 days ago How pharma was instrumental in President Jimmy Carter’s global health efforts - about 2 months ago Big Pharma earnings hang hope on the next generation of blockbusters - 4 months ago Market share shakeup: Big Pharma’s bestselling drugs drive industry shifts in 2024’s first half - 7 months ago Has pharma emerged from the ‘age of uncertainty’? - 8 months ago Avoiding the pharma ‘junk pile’ with launch readiness, pipeline rigor and ‘quick kills’ - 9 months ago Drug shortages, cost concerns and iffy access — how DTC and telehealth could even the playing field - 10 months ago With a rise in animal-human organ transplants, a drugmaker aims for a new standard of care - 11 months ago Who’s getting left behind in the weight loss bonanza? - 11 months ago Big hopes for schizophrenia treatment rely on a deep pipeline of new approaches - 12 months ago The thorniest questions facing pharma, according to a leading bioethicist - over 1 year ago
2	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	As financial headwinds pick up, pharmas are aiming to squeeze more ROI from their R&D - 26 days ago Pharma’s forecast for 2025: Sowing seeds of a rebound - about 1 month ago 3 closely watched drugs that failed in the clinic - 3 months ago Pharma takes aim at a wily foe — the Epstein-Barr virus - 4 months ago 2024 PharmaVoice 100s: Rare Disease Warriors - 4 months ago 2024 PharmaVoice 100s: Trailblazers - 5 months ago Pharma’s ‘it’ therapy — a new drug class gaining steam - 6 months ago Is anyone taking the world’s priciest drugs? - 6 months ago Neuro drugs are still faltering, despite rising investment - 7 months ago Where competition is heating up in pharma - 9 months ago The biggest questions hanging over pharma in 2024 - about 1 year ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - about 1 year ago 3 standout digital innovations in pharma this year - over 1 year ago PharmaVoice 100s: Entrepreneurs - over 1 year ago
3	Mike Hennessy Jr, President and CEO Pharmacy Times Pro middleweight boxer. UK/Ireland. BoxingSports	Advancing Patient Safety and Health Care Efficiency: The Critical Role of Pharmacists - about 2 months ago Turning the Page - 3 months ago Transforming Cancer Care: Innovations in Immunotherapy and the Critical Role of the Pharmacist - 7 months ago Securing Patient Trust: Advancing Cybersecurity and Training in Health-System Pharmacies - 8 months ago Pharmacists Are Vital to Heart Health - about 1 year ago Assessing the Cognitive Consequences of Certain Medicines Remains a Challenge - over 1 year ago
4	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	The first MASH drug could open the door for others — including GLP-1s - 4 months ago From Mr. Mucus to the Super Bowl, pharma tries offbeat marketing strategies - 4 months ago 3 FDA approval dates to watch in the year’s final push - 6 months ago BMS’ KarXT nears schizophrenia approval, but AbbVie and others wait in the wings - 7 months ago As the GLP-1 market booms, other healthcare companies are cashing in - 8 months ago Pfizer and Lilly are elbowing into the direct-to-consumer market. Will it work? - 10 months ago As antimicrobial resistance looms large, a nonprofit teams up with Big Pharma to intervene - 11 months ago
5	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more - 4 months ago STAT+: Pharmalittle: We’re reading about pharma risks in China, mitigating shortages, and more - 4 months ago STAT+: Pharmalittle: We’re reading about biotech startups, Pfizer’s RSV vaccine, and more - 11 months ago STAT+: Pharmalittle: We’re reading about Europe’s pharma reform, weight-loss meds, and more - 12 months ago STAT+: Pharmalittle: We’re reading about state moves on drug pricing, an asthma med for kids and more - about 1 year ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - about 1 year ago STAT+: Pharmalittle: FDA approvals rebound, abortion pill orders rise, and more news - about 1 year ago STAT+: Pharmalittle: Drugmakers raise prices, pharmacies fear fees, McKinsey settles - about 1 year ago STAT+: Pharmalittle: Sanofi scraps rare-disease drug deal under FTC pressure; patients regain weight after stopping Lilly’s Zepbound - about 1 year ago STAT+: Pharmalittle: FTC challenges ‘inaccurately or improperly’ listed patents; Elliott builds stake in BioMarin - over 1 year ago STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month - over 1 year ago STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties - over 1 year ago
6	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - 6 months ago
7	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Condition Watch, August 2024: Dermatology - 6 months ago Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development - 6 months ago Digital Therapeutics Might Address Gaps in Care for Mental Health Patients - 11 months ago Pharmacy Focus: Limited Series - Celebrity Endorsements in Pharmaceuticals - about 1 year ago Key Market Trends for the Current Specialty Drug Pipeline - over 1 year ago Survey: 72% of Pharmacy Technicians’ Workflow Affected by Drug Shortages - over 1 year ago
8	PT Staff Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	June 2024 Products Column - 9 months ago
9	Deanna Fox, PharmD Pharmacy Times Former journalist. Now comms exec. Capital Region, New York communications	OTC Case Studies: Contraception - 10 months ago
10	Jennifer Gershman, PharmD, CPh, PACS Pharmacy Times Pharmacist. Writes for Pharmacy Times, GoodRx. PharmacyHealthcare	Pharmacists Make Positive Impact Through Clinical Interventions - 12 months ago

Journalists covering Pharmaceuticals